Evidence for a Pathogenic Determinant in HIV-1 Nef Involved in B Cell Dysfunction in HIV/AIDS
- 1 July 2008
- journal article
- research article
- Published by Elsevier BV in Cell Host & Microbe
- Vol. 4 (1), 63-76
- https://doi.org/10.1016/j.chom.2008.05.015
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- In Vitro Treatment of Human Monocytes/Macrophages with Myristoylated Recombinant Nef of Human Immunodeficiency Virus Type 1 Leads to the Activation of Mitogen-Activated Protein Kinases, IκB Kinases, and Interferon Regulatory Factor 3 and to the Release of Beta InterferonJournal of Virology, 2007
- Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cellsNature Immunology, 2006
- Regulation of LIP Level and ROS Formation Through Interaction of H-Ferritin with G-CSF ReceptorJournal of Molecular Biology, 2004
- HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infectionNature, 2003
- Perinuclear Localization and Insulin Responsiveness of GLUT4 Requires Cytoskeletal Integrity in 3T3-L1 AdipocytesPublished by Elsevier BV ,2000
- NFkappaB prevents apoptosis and liver dysfunction during liver regeneration.JCI Insight, 1998
- Virus-specific antibody production and polyclonal B-cell activation in the intestinal mucosa of HIV-infected individualsAIDS, 1995
- Growth stimulation of ferritin of human leukemia cells in vitroZeitschrift für Krebsforschung und Klinische Onkologie, 1995
- The Evolution of Lymphadenopathy and Hypergammaglobulinemia Are Evidence for Early and Sustained Polyclonal B Lymphocyte Activation during Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 1991
- Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1983